earnings
SE
NYSE · SER
Serina Therapeutics, Inc.
Healthcare · Biotechnology
$2.50
Down-$0.07 (-2.72%)
Updated Sep 11, 2026, 1:14 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 33.49M
- P/E ratio
- -2.49
- Dividend yield
- 0.00%
- 52-week range
- $1.22 – $3.29
- Volume
- 68.83K
- Avg. volume
- 27.05K
Price performance
SER price history
1M range · 20 trading sessions · Daily adjusted prices
SER closed at $2.50 after 20 trading sessions, down 12.28% for the selected period.
- Last close
- $2.50
- Period change
- -12.28%
- Period low
- $2.42
- Period high
- $2.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $2.55 | $2.58 | $2.3601 | $2.50 | 68.83K |
| Sep 9, 2026 | $2.75 | $2.78 | $2.35 | $2.57 | 404.46K |
| Sep 8, 2026 | $2.75 | $2.75 | $2.475 | $2.50 | 42.27K |
| Sep 4, 2026 | $2.70 | $2.74 | $2.5121 | $2.73 | 14.95K |
| Sep 3, 2026 | $2.68 | $2.69 | $2.575 | $2.69 | 18.84K |
| Sep 2, 2026 | $2.50 | $2.67 | $2.42 | $2.62 | 70.95K |
| Sep 1, 2026 | $2.40 | $2.54 | $2.38 | $2.50 | 32.64K |
| Aug 31, 2026 | $2.40 | $2.50 | $2.38 | $2.42 | 23.12K |
| Aug 28, 2026 | $2.52 | $2.5299 | $2.41 | $2.46 | 33.96K |
| Aug 27, 2026 | $2.61 | $2.6428 | $2.52 | $2.52 | 29.47K |
| Aug 26, 2026 | $2.67 | $2.70 | $2.5601 | $2.63 | 15.48K |
| Aug 25, 2026 | $2.73 | $2.80 | $2.55 | $2.70 | 27.48K |
| Aug 24, 2026 | $2.77 | $2.855 | $2.63 | $2.63 | 40.46K |
| Aug 21, 2026 | $2.67 | $2.87 | $2.6181 | $2.87 | 46.11K |
| Aug 20, 2026 | $2.64 | $2.695 | $2.5601 | $2.65 | 24.83K |
| Aug 19, 2026 | $2.70 | $2.84 | $2.56 | $2.72 | 158.42K |
| Aug 18, 2026 | $2.71 | $2.8599 | $2.61 | $2.62 | 52.08K |
| Aug 17, 2026 | $2.72 | $2.9162 | $2.64 | $2.85 | 133.5K |
| Aug 14, 2026 | $2.64 | $2.88 | $2.64 | $2.80 | 75.97K |
| Aug 13, 2026 | $2.81 | $2.85 | $2.70 | $2.85 | 54.7K |
Latest SER news
The latest Smart Investors Daily articles mentioning SER.
Stock researchCompany · Forecast
Loading stock research…